Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Logothetis

Showing results (31-40 of 150) with videos related to

Pageof 15
Sort By:
The Journal of Urology|May 1, 1993
Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cellsN M Hoosein, C J Logothetis, L W Chung
The Journal of Urology|March 1, 1985
Testicular cancer in homosexual men with cellular immune deficiency: report of 2 casesC J Logothetis, G R Newell, M L Samuels
Anticancer Research|November 1, 1994
SMS 201-995 in the treatment of refractory prostatic carcinomaC J Logothetis, E A Hossan, T L Smith
Seminars in Oncology|October 1, 1994
The clinical and biological study of androgen independent prostate cancer (AI PCa)C J Logothetis, N M Hoosein, J T Hsieh
Urology|October 1, 1991
Predictive factors for effective salvage therapy of nonseminomatous germ cell tumors of testisM A Dimopoulos, R J Amato, C J Logothetis
Cancer Metastasis Reviews|August 24, 1999
Molecular regulation of cell death and therapeutic strategies for cell death induction in prostate carcinomaB T Gjertsen, C J Logothetis, T J McDonnell
Urology|September 1, 1990
Chemotherapy immediately after surgery for patients with germ cell tumorsA Sella, C J Logothetis, F H Dexeus, et al.
AJR. American Journal of Roentgenology|July 1, 1989
Pulmonary air cyst associated with combination chemotherapy containing bleomycinA Sella, C J Logothetis, F H Dexeus, et al.
Urologic Oncology|January 13, 2011
Estramustine and vinblastine for patients with progressive androgen-independent adenocarcinoma of the prostateR J Amato, J Ellerhorst, C Bui, et al.
Urologic Oncology|January 13, 2011
Absence of antitumor activity with prednisone in patients with progressive androgen-independent prostate carcinomaR J Amato, J Ellerhorst, L Finn, et al.
Pageof 15

Showing results (31-40 of 150) with videos related to

Sort By:
Pageof 15
The Journal of Urology|May 1, 1993
Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cellsN M Hoosein, C J Logothetis, L W Chung
The Journal of Urology|March 1, 1985
Testicular cancer in homosexual men with cellular immune deficiency: report of 2 casesC J Logothetis, G R Newell, M L Samuels
Anticancer Research|November 1, 1994
SMS 201-995 in the treatment of refractory prostatic carcinomaC J Logothetis, E A Hossan, T L Smith
Seminars in Oncology|October 1, 1994
The clinical and biological study of androgen independent prostate cancer (AI PCa)C J Logothetis, N M Hoosein, J T Hsieh
Urology|October 1, 1991
Predictive factors for effective salvage therapy of nonseminomatous germ cell tumors of testisM A Dimopoulos, R J Amato, C J Logothetis
Cancer Metastasis Reviews|August 24, 1999
Molecular regulation of cell death and therapeutic strategies for cell death induction in prostate carcinomaB T Gjertsen, C J Logothetis, T J McDonnell
Urology|September 1, 1990
Chemotherapy immediately after surgery for patients with germ cell tumorsA Sella, C J Logothetis, F H Dexeus, et al.
AJR. American Journal of Roentgenology|July 1, 1989
Pulmonary air cyst associated with combination chemotherapy containing bleomycinA Sella, C J Logothetis, F H Dexeus, et al.
Urologic Oncology|January 13, 2011
Estramustine and vinblastine for patients with progressive androgen-independent adenocarcinoma of the prostateR J Amato, J Ellerhorst, C Bui, et al.
Urologic Oncology|January 13, 2011
Absence of antitumor activity with prednisone in patients with progressive androgen-independent prostate carcinomaR J Amato, J Ellerhorst, L Finn, et al.
Pageof 15